2023-11-10 10:34:00
Siemens Healthineers has met within the framework of the 6th Spanish Breast Congress (6CEMA) to various experts to give some of the keys that personalized medicine can provide to get ahead of breast cancer, highlighting the improvement in accuracy in screening. Thus, in this forum the importance of new techniques and technologies such as artificial intelligence has been highlighted, which are increasingly gaining importance as a useful tool to support the work of breast pathology professionals for the detection and early diagnosis of the disease. Specifically, specialists have highlighted the importance of having a breast density record since they know that dense breast increases the risk of breast cancer. These patients have a complex mammogram that causes some lesions to go unnoticed. It is estimated that it affects the 40 percent of women included in screening. Specifically, by age group, around 50 percent of women aged 40, 40 percent of women aged 50, and 25 percent of women over 60 have dense breasts.
Get ahead of breast cancer
Regarding how measuring breast density can help prevent breast cancer, Miguel Chiva de Agustín, head of the Breast Radiology section at the Ramón y Cajal hospital, has insisted that it is necessary have algorithms, software or automated systems to measure and quantify breast density. “Radiologists, although we are experts in mammography, are not capable of having a unified criterion and there is a lot of variability. More objective and reliable quantitative automatic methods are needed.” For her part, Marina Pollán Santamaría, scientific director of CIBERESP (dedicated to Epidemiology and Public Health), insisted on the importance of identifying those women who are most at risk of developing breast cancer due to age, personal and family history, breast density. , genetic mutations and hereditary syndromes, but also taking into account their habits and risk factors is the desired objective for Dr. Pollán, also an expert in prevention in Public Health.
New tomosynthesis systems
In this sense, breast MRI has a high detection rate, but it is a long and poorly accessible technique. Thus, for Chiva, the Tomosynthesis is a fundamental technology for the detection of breast cancer. This has a key role for patients with dense breasts, risk of cancer or palpable pathologies, also favoring the early detection of this type of tumor. So, Siemens presenta Mammomat B.brilliant, a new mammography system with tomosynthesis essential for the detection of breast cancer. It is the fastest wide-angle tomosynthesis on the market, creating a 3D image with high depth resolution in the shortest possible time. In addition, the new ComfortMove function frees users from physical effort, ensuring that doctors can easily and quickly adapt the device to the patient’s anatomy. ComfortMove, display and a positioning laser help significantly speed up scan preparation.
1699622485
#keys #personalized #medicine #ahead #breast #cancer